Tolosa Hunt

  • October 2019
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Tolosa Hunt as PDF for free.

More details

  • Words: 320
  • Pages: 18
HISTORY

EXAM  Afebrile L

hp  Decreased EOM, no visual change, excessive tearing  Mild sinus TTP

LABS  8/9

UA, C&S: >100,0000 proteus m.  8/9 WBC=17.3  8/10 CT  8/13 MRI  8/19 CTA  8/19 MRA

ANATOMY OF CAVERNOUS SINUS

DDX OF CAVERNOUS SINUS LESIONS  Orbital

cellulitis  Opthalmoplegic Migraine  Carotid Cavernous Sinus Fistula  Mucormycosis  Tolosa Hunt Syndrome

 Temporal

arteritis  Orbital Pseudotumor  Carotid Artery Dissection or aneurysm  Neoplasm: lymphoma, meningioma

CSL SYMPTOMS  PTOSIS,

PROPTOSIS, CHEMOSIS, PAINFUL OPTHALMOPLEGIA W/O PROPTOSIS  HEADACHE: UNILATERAL OR RETROORBITAL  DECREASED VISUAL ACUITY AND DIPLOPLIA  SENSORY LOSS: FACE, FOREHEAD, PERIORBITAL REGIONS

CSL SIGNS  PERIORBITAL

EDEMA  PTOSIS  PROPTOSIS  OPTHALMOPLEGIA  CHEMOSIS  FEVER  PAPILLEDEMA  TACHYCARDIA

 TACHYCARDIA  FACIAL

CELLULITIS  DECREASED VISUAL ACUITY  NUCHAL RIGIDITY  SEIZURES

CSL DIAGNOSTIC WORKUP  DIAGNOSIS

OF EXCLUSION

 H&P  MRI/MRA  CBC  CT  SPECIALIST

CONSULT: NSG, ID, GS

CSL M&M  VISUAL

LOSS

 DEATH  THROMBOTIC

EVENTS  COGNITIVE DEFICITS

TOLOSA-HUNT SYNDROME  EPIDEMIOLOGY  PATHOPHYSIOOLOGY  MORBIDITY

AND MORTALITY  TREATMENT  PROGNOSIS

THS PATHOPHYSIOLOGY  Cause

unknown  Granulomatous or primarily lymphocytic infiltration of cavernous sinus and superior orbital fissure

THS EPIDEMIOLOGY  Uncommon  Men=women  Age>20  Usually

around age 60

THS SYMPTOMS  HA  ARTHRALGIA  FEVER  VERTIGO  DOUBLE

VISION

THS SIGNS/SYMPTOMS  PTOSIS

 HA

 EXOPTHALMOS

 ARTHRALGIA

 OPTHALMOPLEGIA

 FEVER

 DIPLOPLIA  VERTIGO  CHRONIC

FATIGUE

THS DIAGNOSIS PEARLS  DIAGNOSIS

OF EXCLUSION

THS TREATMENT  IMMUNOSUPPRESSION  STEROIDS  METHOTREXATE

 RADIOTHERAPY  PAIN

CONTROL

 ACETOMINOPHEN  STEROIDS

THS PROGNOSIS  Benign  Spontaneous

resolution may occur  Relapses (30-40%)  Nearly always improves w/ steroids  Pain(

24-72 hrs)  Visual loss possible if untreated  Vision

and facial numbness resolves in weeks to months

UPDATE

Related Documents

Tolosa Hunt
October 2019 7
Tolosa Hunt Md Consult
October 2019 13
Hunt
October 2019 43
Bison Hunt
June 2020 4
Scavenger Hunt
December 2019 24
Egg Hunt
April 2020 15